BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Prognosis
10 results:

  • 1. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
    Brozos-Vázquez E; Toledano-Fonseca M; Costa-Fraga N; García-Ortiz MV; Díaz-Lagares Á; Rodríguez-Ariza A; Aranda E; López-López R
    Cancer Treat Rev; 2024 Apr; 125():102719. PubMed ID: 38490088
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma.
    Chapin WJ; Reiss KA
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):1019-1032. PubMed ID: 36154785
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis.
    Drumond-Bock AL; Bieniasz M
    Mol Cancer; 2021 Nov; 20(1):145. PubMed ID: 34758842
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Ductal adenocarcinoma of the pancreas: subtypes and molecular pathology].
    Schlitter AM; Konukiewitz B; Kasajima A; Reichert M; Klöppel G
    Pathologe; 2021 Sep; 42(5):464-471. PubMed ID: 34402977
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients.
    Zheng H; Zhang M; Ma S; Yang W; Xie S; Wang Y; Liu Y; Kai J; Ma Q; Lu R; Guo L
    Cancer Med; 2020 Jul; 9(14):5200-5209. PubMed ID: 32441484
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
    Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
    Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. prognosis Relevance of Serum Cytokines in Pancreatic cancer.
    Torres C; Linares A; Alejandre MJ; Palomino-Morales RJ; Caba O; Prados J; Aránega A; Delgado JR; Irigoyen A; Martínez-Galán J; Ortuño FM; Rojas I; Perales S
    Biomed Res Int; 2015; 2015():518284. PubMed ID: 26346854
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of Qcancer(®) (Pancreas).
    Collins GS; Altman DG
    Br J Gen Pract; 2013 Sep; 63(614):e636-42. PubMed ID: 23998844
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
    Eichhorn JH; Young RH; Clement PB; Scully RE
    Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.